pCPA File Number:
20769
Negotiation Status:
Concluded without agreement
Indication(s):
Atypical hemolytic uremic syndrome
Sponsor/Manufacturer:
Alexion Pharma Canada Corp.
CDA-AMC Project Number:
SR0304-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: